Academic Journal
Integration of Bulk RNA Sequencing and Single-Cell Sequencing to Identify Prognostic Genes Associated With MCDRGs in Neuroblastoma.
| Τίτλος: | Integration of Bulk RNA Sequencing and Single-Cell Sequencing to Identify Prognostic Genes Associated With MCDRGs in Neuroblastoma. |
|---|---|
| Συγγραφείς: | Lin J; Department of Pediatric Urology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.; Sichuan Provincial Children's Hospital (Sichuan Provincial Children's Medical Center), Meishan, Sichuan, China., Gao Z; Shenzhen Medical Academy of Research and Translation, Shenzhen, Guangdong, China.; Department of Urology, Children's Hospital of Chongqing Medical University, Chongqing, China., Qin D; Department of Pediatric Urology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.; Sichuan Provincial Children's Hospital (Sichuan Provincial Children's Medical Center), Meishan, Sichuan, China., Huang H; Department of Pediatric Urology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.; Sichuan Provincial Children's Hospital (Sichuan Provincial Children's Medical Center), Meishan, Sichuan, China., Zhang Z; Department of Pediatric Urology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.; Sichuan Provincial Children's Hospital (Sichuan Provincial Children's Medical Center), Meishan, Sichuan, China., Liu F; Department of Pediatric Urology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China.; Sichuan Provincial Children's Hospital (Sichuan Provincial Children's Medical Center), Meishan, Sichuan, China. |
| Πηγή: | FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2026 Aug 31; Vol. 40 (16), pp. e72175. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2020- : [Bethesda, Md.] : Hoboken, NJ : Federation of American Societies for Experimental Biology ; Wiley Original Publication: [Bethesda, Md.] : The Federation, [c1987- |
| Ιατρικοί όροι (MeSH): | Neuroblastoma*/genetics , Neuroblastoma*/pathology , Single-Cell Analysis*/methods , Sequence Analysis, RNA*/methods , Myeloid Cells*/metabolism , Myeloid Cells*/pathology , Biomarkers, Tumor*/genetics , Gene Expression Regulation, Neoplastic*, Tumor Microenvironment/genetics ; Cell Differentiation/genetics ; Humans ; Prognosis ; Single-Cell Gene Expression Analysis ; Transcriptome ; Gene Expression Profiling |
| Περίληψη: | Neuroblastoma (NB) is a common pediatric tumor that exhibits significant clinical heterogeneity and substantial prognostic variability. However, there is still a lack of effective prognostic tools. It has been found that the differentiation of myeloid cells in the tumor microenvironment (TME) has a profound influence on tumor progression and immune regulation in neuroblastoma. But the correlation between NB and myeloid cell differentiation-related genes (MCDRGs) is still unclear. This study integrated bulk and single-cell RNA sequencing data to identify key prognostic genes associated with myeloid cell differentiation, construct and validate a risk prediction model, and thoroughly investigate the molecular mechanisms through which these genes regulate the TME and influence NB prognosis. Using bioinformatic approaches, we retrieved NB-related transcriptomic data from public databases, identified differentially expressed myeloid cell differentiation-related genes (MCDRGs), and constructed a prognostic risk model using Cox regression and machine-learning algorithms. Functional enrichment analysis, TME characterization, immune checkpoint profiling, drug sensitivity analysis, and somatic mutation analysis were performed between the high-risk group (HRG) and low-risk group (LRG). Single-cell RNA sequencing data were used to dissect the cell type-specific expression patterns of prognostic genes, which were further experimentally validated via reverse transcription quantitative polymerase chain reaction (RT-qPCR). Five key prognostic genes (FAXDC2, GP1BB, TRIB1, ETV2, and H4C12) were identified from 187 candidate genes, and a robust risk prediction model was constructed. Significant differences were observed between the HRG and LRG in terms of TME scores, immune cell infiltration, and immune checkpoint expression. Ribosome biogenesis and cell cycle-related pathways were enriched in the HRG, which displayed higher sensitivity to entinostat and sapitinib. Single-cell analysis further highlighted fibroblasts and myeloid cells as key cell subsets in which prognostic genes exhibited dynamic expression patterns. RT-qPCR further validated these gene expression trends. The prognostic model based on MCDRGs effectively predicts survival outcomes in patients with NB. This model systematically reveals the comprehensive mechanisms by which MCDRGs influence prognosis through regulating the TME, cell-cell interactions, and therapeutic responses. These findings provide a new theoretical basis and potential targets for precise risk stratification and individualized treatment strategies in NB. (© 2026 Federation of American Societies for Experimental Biology.) |
| References: | Genome Biol. 2014;15(12):550. (PMID: 25516281) Front Immunol. 2020 May 08;11:873. (PMID: 32457760) Med Res Rev. 2021 Mar;41(2):961-1021. (PMID: 33155698) Brief Bioinform. 2021 Jan 18;22(1):140-145. (PMID: 31813948) Mol Ther. 2025 Sep 3;33(9):4552-4569. (PMID: 40437756) J Open Source Softw. 2020;5(49):. (PMID: 36919162) J Clin Oncol. 1988 Jan;6(1):44-50. (PMID: 3335892) Oncoimmunology. 2013 Jul 1;2(7):e24658. (PMID: 24073359) J Stat Softw. 2010;33(1):1-22. (PMID: 20808728) Bioinformatics. 2022 Aug 2;38(15):3844-3846. (PMID: 35751589) Innovation (Camb). 2021 Jul 01;2(3):100141. (PMID: 34557778) Semin Diagn Pathol. 2022 Mar;39(2):120-130. (PMID: 34167847) Biotechnol Bioeng. 2023 Sep;120(9):2756-2764. (PMID: 37227044) Vet Clin North Am. 1977 Feb;7(1):21-33. (PMID: 322381) Genome Res. 2018 Nov;28(11):1747-1756. (PMID: 30341162) J Immunother Cancer. 2025 Mar 06;13(3):. (PMID: 40050048) J Hematol Oncol. 2021 Nov 12;14(1):191. (PMID: 34772439) Cancer Lett. 2012 Jun 1;319(1):23-30. (PMID: 22182450) Cancer Lett. 2016 Sep 28;380(1):304-14. (PMID: 26597947) Neoplasia. 2024 Jun;52:100997. (PMID: 38669760) Brief Bioinform. 2021 Nov 5;22(6):. (PMID: 34260682) Lancet Psychiatry. 2023 Apr;10(4):e10. (PMID: 36495895) Sci Rep. 2023 Aug 1;13(1):12424. (PMID: 37528172) Cancers (Basel). 2022 Feb 17;14(4):. (PMID: 35205759) Nat Genet. 2025 May;57(5):1142-1154. (PMID: 40229600) Signal Transduct Target Ther. 2018 Feb 9;3:4. (PMID: 29527330) Genome Res. 2003 Nov;13(11):2498-504. (PMID: 14597658) J Surg Oncol. 2023 Sep;128(4):510-518. (PMID: 37272486) Exp Hematol Oncol. 2024 Apr 12;13(1):39. (PMID: 38609997) Int J Mol Sci. 2024 Sep 07;25(17):. (PMID: 39273649) J Immunother Cancer. 2023 May;11(5):. (PMID: 37130627) J Exp Clin Cancer Res. 2024 Oct 22;43(1):292. (PMID: 39438988) Stem Cell Res Ther. 2023 Mar 16;14(1):41. (PMID: 36927793) J Cancer. 2020 Mar 26;11(12):3623-3633. (PMID: 32284759) Sci Rep. 2022 Jul 5;12(1):11340. (PMID: 35790774) Nat Rev Dis Primers. 2016 Nov 10;2:16078. (PMID: 27830764) Nat Rev Immunol. 2023 Feb;23(2):106-120. (PMID: 35697799) Eur J Dent. 2023 Oct;17(4):1215-1220. (PMID: 36812928) Front Cardiovasc Med. 2022 Jun 30;9:906753. (PMID: 35845045) Sci Adv. 2023 Mar 15;9(11):eadd3243. (PMID: 36930718) Cancers (Basel). 2022 Dec 20;15(1):. (PMID: 36612020) Oncoimmunology. 2022 Dec 1;11(1):2146860. (PMID: 36479153) Nat Biotechnol. 2014 Apr;32(4):381-386. (PMID: 24658644) Blood Cancer J. 2016 Sep 30;6(9):e478. (PMID: 27689744) Clin Transl Med. 2022 Mar;12(3):e694. (PMID: 35352511) Cancers (Basel). 2021 Jun 19;13(12):. (PMID: 34205360) Adv Exp Med Biol. 2024;1459:159-195. (PMID: 39017844) Methods. 2001 Dec;25(4):402-8. (PMID: 11846609) Cancers (Basel). 2021 Apr 06;13(7):. (PMID: 33917501) Cancer. 2004 Nov 15;101(10):2257-60. (PMID: 15484215) Bioinformatics. 2022 Feb 7;38(5):1460-1462. (PMID: 34864868) Cell Immunol. 2025 Jan;407:104898. (PMID: 39631142) J Clin Invest. 2024 Jan 23;134(6):. (PMID: 38488003) Platelets. 2022 Feb 17;33(2):324-327. (PMID: 33813986) Children (Basel). 2018 Aug 28;5(9):. (PMID: 30154341) Cell Death Discov. 2024 Jan 4;10(1):1. (PMID: 38172127) Nat Commun. 2013;4:2612. (PMID: 24113773) Brief Bioinform. 2021 Nov 5;22(6):. (PMID: 34329375) Biometrics. 2000 Jun;56(2):337-44. (PMID: 10877287) Methods Mol Biol. 2020;2120:223-232. (PMID: 32124323) Nat Rev Clin Oncol. 2022 Aug;19(8):515-533. (PMID: 35614230) Crit Rev Oncol Hematol. 2016 Nov;107:163-181. (PMID: 27823645) Purinergic Signal. 2025 Feb;21(1):51-68. (PMID: 39425818) Nat Biotechnol. 2015 May;33(5):495-502. (PMID: 25867923) |
| Grant Information: | KZ317 K Foundation of West China Second University Hospital, Sichuan University |
| Contributed Indexing: | Keywords: Neuroblastoma; myeloid cell differentiation; prognostic genes; risk model |
| Substance Nomenclature: | 0 (Biomarkers, Tumor) |
| Entry Date(s): | Date Created: 20260814 Date Completed: 20260814 Latest Revision: 20260816 |
| Update Code: | 20260816 |
| PubMed Central ID: | PMC13475957 |
| DOI: | 10.1096/fj.202601255R |
| PMID: | 42600038 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!